Alkermes
disciplined capital allocation supports highest roi priorities advance alfa initiate studies to support potential registration pathways in mucosal melanoma and platinum resistant ovarian cancer continued enrollment in artistry dose expansion evaluating subcutaneous anti tumor activity continue to build objective response data in multiple tumor types in artistry and artistry go | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
29 of 144
Related slides by other companies
Crocs
Investor Presentation
March 2023
capital allocation priorities | Crocs
Lamb Weston
Results
January 2018
capital allocation priorities | Lamb Weston
Tapestry
Investor Presentation
May 2022
capital allocation priorities capital to shareholders | Tapestry
Owens&Minor
Investor Day
December 2023
disciplined capital allocation strategy | Owens&Minor
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io